聚糖:提取,净化和功能活动的治疗前景
Kit-Leong Cheong1, Wenjie Chen1, Min Wang2
1Guangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.
Marine drugs
|April 25, 2025
概括
Undaria pinnatifida 多糖体显示出显著的健康益处,包括抗氧化和抗癌特性. 本综述详细介绍了它们的提取,表征和在功能性食品和制药中的应用.
科学领域:
- 海洋生物技术 海洋生物技术
- 食品科学 食品科学 食品科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 棕色海藻Undaria pinnatifida因其健康益处而闻名.
- 多糖是Undaria pinnatifida中的关键生物活性化合物,具有多种生物活性.
研究的目的:
- 为了提供Undaria pinnatifida多糖的全面概述.
- 要总结最近在提取,净化,结构特征和生物活性方面的进展.
主要方法:
- 审查最先进的提取技术 (超声波辅助,微波辅助,酶辅助).
- 讨论净化策略 (膜分离,色谱).
- 对已记录的生物活动和作用机制进行分析.
主要成果:
- 对于Undaria pinnatifida多糖的提取和净化方法正在进步.
- 这些多糖体具有显著的抗氧化,免疫调节,抗癌,促进肠道健康和抗高血糖作用.
- 这些生物活性背后的机制正在被阐明.
结论:
- Undaria pinnatifida 多糖具有功能性食品和制药的巨大潜力.
- 根据它们的多样化的生物活性,对它们的应用进行进一步的研究是有必要的.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Therapeutic Index
4.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.0K
Drug Administration and Therapy Phases: Overview
385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K


